Aikido Pharma authorizes $2M buyback, plans name change to Dominari Holdings

Dominari Holdings Inc.

Board authorized share repurchase up to $2M; may execute via 10b5-1 plan.
Company to change name to Dominari Holdings to reflect shift to financial services.
Acquired 100% of Fieldpoint Private Securities, pending FINRA approval; will become Dominari Securities.
Approximately $3.2M capital deployed for Dominari Financial and Dominari Securities operations.
Company actively recruiting and building operations space for financial services subsidiary.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Dominari Holdings Inc. shareholders approved Ratification of appointment of Marcum, LLP as independent registered public accounting firm at the 2022-12-05 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2022-12-05

Exact text from the filing

The appointment of Marcum, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 was ratified. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 2,772,891 141,000 23,215 -

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Dominari Holdings Inc. shareholders approved Adoption of 2022 Equity Incentive Plan at the 2022-12-05 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2022-12-05

Exact text from the filing

The adoption of the 2022 Equity Incentive Plan was approved. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 1,281,570 678,219 13,667 963,650

View on SEC.gov

352 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Dominari Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-077790

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.